Venous thromboembolism prophylaxis in a South Australian teaching hospital

Annals of Pharmacotherapy

Volumn 37, Issue 10, 2003, Pages 1398-1402

  Learhinan, Elizabeth R ^a   Alderman, Christopher P ^a  

^a REPATRIATION GENERAL HOSPITAL   (Australia)

Author keywords

Australia; Prophylaxis; Thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ARTICLE; AUSTRALIA; COHORT ANALYSIS; FEMALE; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; THROMBOSIS PREVENTION; VEIN THROMBOSIS;

AGED; DATA COLLECTION; DECISION MAKING; FEMALE; HEALTH CARE RATIONING; HOSPITALS, TEACHING; HUMANS; MALE; MORBIDITY; PATIENT SELECTION; PRACTICE GUIDELINES; PROSPECTIVE STUDIES; SOUTH AUSTRALIA; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT FAILURE; VENOUS THROMBOSIS;

EID: 0141669312     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1D100     Document Type: Article

References (16)

1. Laffan M, Tuddenham E. Assessing thrombotic risk (science, medicine and the future). BMJ 1998;317:520-4.
2. Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J R Soc Med 1989;82:203-5.
3. Prandoni P, Lensing A, Cogo A, Cuppini S, Villalta S, Carta M, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996;125:1-7.
4. Franzeck UK, Schalch I, Jäger KA, Schneider E, Grimm J, Bollinger A. Prospective 12-year follow-up study of clinical and hemodynamic sequelae after deep vein thrombosis in low-risk patients (Zürich Study). Circulation 1996;93:74-9.
5. Lowe GDO, Greer IA, Cooke TG, Dewar EP, Evans MJ, Forbes CD, et al. Thromboembolic Risk Factors (THRIFT) Consensus Group. Risk of and prophylaxis for venous thromboembolism in hospital patients. BMJ 1992;305:567-74.
6. Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. N Engl J Med 1988;318:1162-73.
7. Salzman EW, Davies GC. Prophylaxis of venous thromboembolism: analysis of cost effectiveness. Ann Surg 1980;191:207-18.
8. Clagett GP, Anderson FA, Geerts W, Heit JA, Knudson M, Lieberman JR, et al. Prevention of venous thromboembolism. Chest 1998; 114(suppl):531S-60S.
9. Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA Jr, et al. Prevention of venous thromboembolism: sixth ACCP Consensus Conference on Antithrombotic Therapy. Chest 2001;119(1 suppl):132S-75S.
10. Samama MM, Cohen AT, Darmon JY, Desjardins L, Eldor A, Janbon C, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients (MEDENOX). N Engl J Med 1999;341:793-800.
11. Anderson FA, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT study. Arch Intern Med 1991;151:933-8.
12. Anderson FA, Wheeler BH, Goldberg RJ, Hosmer DW, Forcier A, Patwardhan NA. Changing clinical practice: prospective study of the impact of continuing medical education and the quality assurance programs on use of prophylaxis for venous thromboembolism. Arch Intern Med 1994;154:669-77.
13. Fletcher JP, Koutts J, Ockelford PA. Deep vein thrombosis prophylaxis: a survey of current practice in Australia and New Zealand. Aust N Z J Surg 1992;62:601-5.
14. Laverick MD, Croal SA, Mollan RAB. Orthopaedic surgeons and thromboprophylaxis. BMJ 1991;303:549-50.
15. Clagett GP, Reisch JS. Prevention of venous thromboembolism in general surgical patients: results of meta-analysis. Ann Surg 1988;208:227-40.
16. Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995;332:1330-5.